藥物成份

共有 21676 個藥物成份

２１　５：４

• 關聯藥證數量: 1

２６　２：４

• 關聯藥證數量: 1

３０　度米酒

• 關聯藥證數量: 1

３０度以上米

• 關聯藥證數量: 1

３０度米加至

• 關聯藥證數量: 1

３０度米酒至

• 關聯藥證數量: 1

９５％酒精加

• 關聯藥證數量: 1

？ Strip：Cellulose Acetate supported on Mylar® ？ Soaking and buffer Running Contains: 1.02% Tris(hydroxyl-methyl-amino-methane).？ Staining Solution Contains: Ponceau S Red, 1-5% Trichloroacetic acid.？ Destaining Solution Contains：Citric Acid, 2.5%b (w/v) ？ Clearing Solution Contains：32% N-Methyl-2-pyrrolidone, 8.0% Ethanol, 7.0% Acetic acid, 1.0% Methanol.

• 關聯藥證數量: 1

？ (A)溶解用液(液狀)？ (B)血清稀釋用液(液狀)？ (C)感作粒子(凍乾品): 復元後含1% Treponema Pallidum (Nichols株)感作之 Gelatin粒子？ (D)未感作粒子(凍乾品): 復元後含1% Tannic Acid 處理之Gelatin粒子？ (E)對照用陽性血清(液狀):以抗Treponema Pallidum (Nichols株)陽性血清調製， 抗體力價為1:80

• 關聯藥證數量: 1

？ 50 individually wrapped test devices with disposable transfer pipet.Each test cassette contains one test strip with H. pylori antigen coated membrane, colored H. pylori antigen pad.？ Developer Buffer (8 ml): 50mM Tris-HCl buffer with 0.02% sodium azide

• 關聯藥證數量: 1

？ ANA Coated Well: 12 x 8 well strips coated with a mixture of purified antigens (dsDNA, histone, SSA/Ro (60 and 52Kd), SSB/La, Sm, Sm/RNP, Scl-70, Jo-1, centemeric Antigen).\n？ Type III Wash Buffer 20x concentrate: 1 bottle containing 50 mL of a 20x concentrated buffer for washing the wells.\n？ Type III Sample Diluent: 2 bottles containing 50 mL of buffer for diluting the samples. Ready to use.\n？ ANA Screen Cut-off Control: 1 bottle containing 1.8 mL of duluted stabilized human serum. The expected ANA result is given on the QC certificate. Ready to use.\n？ ANA Screen Positive Control: 1 bottle containing 1.8 mL of duluted stabilized human serum. The expected ANA result is given on the QC certificate. Ready to use.\n？ ANA Negative Control: 1 bottle containing 1.8 mL of duluted stabilized human serum. The expected ANA result is given on the QC certificate. Ready to use.\n？ ANA Screen Conjugate: 1 bottle containing 12 mL of peroxidase labelled antibody to human IgG. Coloured red, ready to use.\n？ TMB Substrate

• 關聯藥證數量: 1

？ DR-70® Antibody-Coated Wells, (96 well Plate)？ Enzyme Antibody Conjugate？ Low Control？ High Control？ DR-70® calibrators: 5 vials (500μl each) at concentrations of: 0, 0.625, 2.5, 5.0, and 10.0 μg/ml？ Diluent Buffer Concentrate (5X)？ Wash Buffer Concentrate (20X)？ TMB Substrate ？ Stop Solution？ Dilution/Transfer Plate (96 well uncoated Plate)

• 關聯藥證數量: 1

？ ID-Card “Anti-A, absorbed” with 6 microtubes containing Anti-A1, human within the gel matrix.\nPreservative: <0.1% NaN3. \n

• 關聯藥證數量: 1

？ ID-Card “Coombs Anti-IgG” with 6 microtubes containing anti-human globulin anti-IgG (rabbit), within the gel matrix.\nPreservative: <0.1% NaN3. \n

• 關聯藥證數量: 1

？ ID-Card “LISS/Coombs” with 6 microtubes containing polyspecific AHG (rabbit anti-IgG and monoclonal anti-C3d, cell line C139-9) within the gel matrix.\nPreservative: <0.1% NaN3. \n

• 關聯藥證數量: 1

？ ID-Card “NaCl, enzyme test and cold agglutinins” with 6 microtubes containing neutral gel suspension. \nPreservative: <0.1% NaN3. \n

• 關聯藥證數量: 1

？ ID-Card “Typing of Partial Rh D” with 6 microtubes containing polyspecific anti-human globulin [rabbit anti-IgG and monoclonal anti-C3d (cell line C139-9)], within the gel matrix (containing bovin albumin).\nPreservative: <0.1% NaN3. \n

• 關聯藥證數量: 1

？ Instruction Leaflet\n？ QC Certificate\n？ ENA Profile Coated Wells: 12 x 8 well strips in witch each of wells is coated with purified ENA antigens.\n？ Type III Wash Buffer 20x concentrate: 1 bottle containing 50 mL of 20x concentrated buffer.\n？ Type III Sample Diluent: 1 bottle containing 50 mL of buffer.\n？ ENA Profile Cut-off Control: 1 bottle containing 1.6 mL of diluted stabilized human serum.\n？ ENA Profile Positive Control: 1 bottle containing 1.6 mL of diluted stabilized human serum.\n？ ENA Profile Conjugate: 1 bottle containing 1.2 mL of peroxidase labeled antibody to human IgG.\n？ TMB Substrate: 1 bottle containing 14 mL TMB substrate.\n？ Stop Solution: 1 bottle containing 14 mL of 3 M phosphoric acid. \n\n

• 關聯藥證數量: 1

？ Pre-optimized and tested mixture of microspheres with probes covalently attached\n？ Hybridization reaction buffers to facilitate the binding of target DNA to the probe\n？ Wash Buffer to wash off unbound DNA\n？ SAPE buffer for diluting Stock SAPE solution\n？ DNA amplification reagents (pre-optimized HLA loci-specific primer mix).\n？ D-mix (specially formulated amplification).\n\n

• 關聯藥證數量: 1

？ Purified H. pylori antigen coated microtiter plate, 96 wells.\n？ Enzyme Conjugate Reagent (red color), 13 ml.\n？ Sample Diluent (green color), 22 ml.\n？ Negative Control, 150μl.\n？ Cut-off Calibrator, H. pylori IgG EIA Index=1,150 μl.\n？ Positive Control, 150μl.\n？ Wash Buffer (20x), 50 ml.\n？ TMB Reagent (One-Step), 11 ml.\n？ Stop Solution (1N HCl), 11 ml. \n

• 關聯藥證數量: 1

？ 25 x individually packaged test strips. Each strip contains monoclonal antibodies to human IgM and human IgG immobilized in two lines.A control line is also included. Strips contain a pad with purified recombinant dengue protein serotypes (D1, D2, D3, D4) and gold labeled monoclonal anti-dengue virus. ？ 1 x product insert？ 1 x 3ml bottle of phosphate-based buffer (contain 0.1^% sodium azide)？ 30 x 1ul plastic loops

• 關聯藥證數量: 1

？1 Bottle (15.0 mL)<25% Vancomycin II Antiserum (Mouse, Monoclonal。 ？ 1 Bottle (8.6 mL)Pretreatment Solution. ？1 Bottle (15.1 mL)Vancomycin II Fluoresein Tracer. AxSYM Vancomycin II Standard Calibrators 6 Bottles (6 mL A, 4 mL each B-F)of AxSYM Vancomycin II Standard Calibrators,0-100 mg/mL 3 Bottles (8 mL each) of AxSYM Vancomycin II Controls,L , M, H~7, 35, 75 mg/L

• 關聯藥證數量: 1

？25.0 mg Sodium Hyaluronate (NaHA)\n？22.5 mg NaCl\n？1.0 mg Na2HPO4\n？0.035 mg NaH2PO4\n？Water for injection q.s.\n？pH 6.8-7.5\n\n

• 關聯藥證數量: 1

？3 x 5ml R1 (extraction reagent)\n？1 x 1ml R2 (positive control containing non-infective chlamydial antigen)\n？individually foil-wrapped devices\n？extraction Tubes

• 關聯藥證數量: 1

？Glucose：16.3% w/w glucose oxidase （Aspergillus niger, 1.3 IU）; 0.6% w/w peroxidase （horseradish, 3300 IU）; 7.0% w/w potassium iodide ; 76.1% w/w buffer and non-reactive ingredients.\n？Protein：0.3% w/w tetrabromophenol blue ; 99.7% w/w buffer and nonreactive ingredients.\n？pH：0.2% w/w methyl red ; 2.8% w/w bromothymol blue ; 97% w/w nonreactive ingredients.\n？Specific Gravity：2.8% w/w bromothymol blue, 69.0% ; poly (methyl vinylether/maleic anhydride) ; 28.2% sodium hydroxide.\n

• 關聯藥證數量: 1

？Instruction Leaflet: Giving full assay details.\n？QC Certificate: Indicating the expected performance of the batch.\n？MPO Coated Wells:12 breakapart 8 well strips coated with MPO antigen, colour coded green. Each plate is packaged in a re-sealable foil bag containing 2 desiccant pouches.\n？ANCA Sample Diluent: 2 bottles containing 50mL of buffer for sample dilution. Coloured yellow.\n？Wash Buffer: 1 bottle containing 50mL of a 20-fold concentrated buffer for washing the wells.\n？MPO Calibrators: 5 bottles each containing 1.2mL of diluted human serum, with the following concentrations of anti-MPO antoantibody: 100, 33.3, 11.1, 3.7, 1.23 U/mL.\n？MPO Positive Control: 1 bottle containing 1.2mL of diluted human serum.\n？MPO Negative Control: 1 bottle containing 1.2mL of diluted human serum.\n？MPO Conjugate: 1 bottle containing 12mL of purified peroxidase labelled antibody to human IgG. Coloured red.\n？TMB Substrate: 1 bottle containing 14mL TMB substrate.\n？Stop Solution: 1 bottle containing 14mL of 3M phosphori

• 關聯藥證數量: 1

？Murine Monoclonal anti-CA125 coated microtiter plate with 96 wells.\n？Enzyme Conjugate Reagent, 13 ml.\n？CA125 reference standards containing; 0, 15, 50, 100, 200, and 400Unit/ml of CA125, 1 ml each.\n？TMB Reagent, 11 ml\n？Stop Solution (1N HCl), 11 ml.

• 關聯藥證數量: 1

？PC CMVIGG2: 8 bottles, each containing 1.0 mL of control serum Human serum, positive for CMV IgG antibodies (approx.25 U/mL); preservative.

• 關聯藥證數量: 1

？R-PRT200 (peach top) contains protamine sulfate (0.04 mg), dlatomaceous earth, stabillzers and buffers.\n？R-PRT200K (peach top) contains protamine sulfate (0.04 mg), kaolin, stabillzers and buffers.\n？R-PRT400 (red top) contains protamine sulfate (0.08 mg), dlatomaceous earth, stabillzers and buffers.\n？R-PRT400K (red top) contains protamine sulfate (0.08 mg), kaolin, stabillzers and buffers.

• 關聯藥證數量: 1

？R1：1M Sodium nitrite 4.5ml\n？R2：1M Acetic acid 4.5ml\n？R3：1.6M Tris buffer (contains less than 0.1% sodium azide) 4.5ml\n？R4：Positive Control. Acid-extracted antigen of group A streptococci (contains less than 0.1% sodium azide) 1.0ml\n？Clearview Strep A devices.\n？Throat Swabs\n？Extraction Tubes

• 關聯藥證數量: 1

？Reagent 1 (R1) 10 x 21 mL？Bar code labeled cartridges (10)reactive Ingredient：L-Aspartate, K：240.5 mmol/L，Succinic Acid：20.5 mmol/L，Sodium α-Ketoglutarate：11.8 mmol/L，Pyridoxal-5’-phosphate：0.10 mmol/L，MD：420 U/L，LD：600 U/L，TRIS：81.2 mmol/L，EDTA：5.9 mmol/L，NADH：0.33 mmol/L。

• 關聯藥證數量: 1

？Reagent 1 (R1) 6 x 20 mL？Liquid Stabilizer 2 x 20 mL？Funnels (6)？Bar code labeled cartridges (6)R1: α-Naphthylphosphate Disodium Salt：3 mmol/L, 4-Chloro-2-Methylbenzenediazonium Salt：1 mmol/L。Liquid Stabilizer: Acetate Buffer：3 mol/L。

• 關聯藥證數量: 1

？Standard filter paper(Hereafter“SFP”) with 7 concentrations of 2, 4, 6, 8, 10, 16, 20 mg/dl of Galactose-1-phosphate Uridyltransferase：\n1.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (2 mg/dl)：1 SFP/Kit\n2.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (4 mg/dl)：1 SFP/Kit\n3.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (6 mg/dl)：1 SFP/Kit\n4.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (8 mg/dl)：5 SFP/Kit\n5.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (10 mg/dl)：1 SFP/Kit\n6.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (16 mg/dl)：1 SFP/Kit\n7.SFP with standard concentration of Galactose-1-phosphate Uridyltransferase (20 mg/dl)：1 SFP/Kit

• 關聯藥證數量: 1

？test devices, each sealed in a pouch with a dropper pipette and a desiccant\n？package insert

• 關聯藥證數量: 1

？本浸膏

• 關聯藥證數量: 1

？牡蠣

• 關聯藥證數量: 1

？牡蠣末

• 關聯藥證數量: 1

？甲浸膏

• 關聯藥證數量: 1

？藤釣

• 關聯藥證數量: 1

？藤？

• 關聯藥證數量: 1

？血清稀釋用液(液狀)： 30ml/vial x1 檢體稀釋與感作粒子及未感作粒子 之復元用液？感作粒子(凍&#20097;品)： 1.5ml*/vial x5 Mycoplasma抗原感作Gelatin粒子之凍&#20097;品, (*溶解復元後之volume) 復元後含0.9%Mycoplasma抗原感作Gelatin粒子？未感作粒子(凍&#20097;品)： 0.6ml*/vial x3 Tannic Acid處理之Gelatin粒子 (*溶解復元後之volume)？(E)對照用陽性血清(液狀)： 0.5ml/vial x1 Mycoplasma pneumoniae(Mac 株)抗體陽性兔血清以血清稀釋用液10倍稀釋調製，抗體價 1：320(最終稀釋倍數)

• 關聯藥證數量: 1

？頭

• 關聯藥證數量: 1

？（A）Reconstitution Solution (Liquid):For use in reconstituting Sensitized Particles and Unsensitized Particles and Positive Control. ？（B）Sample Diluent (Liquid): For use in diluting Specimens. ？（C）Sensitized Particles (Lyophilized): Lyophilized preparation of gelatin particles sensitized with Denatured rabbit IgG. ？（D）Unsensitized Particles (Lyophilized): Lyophilized preparation of tanned gelatin particles. ？（E）Positive Control (Lyophilized): Lyophilized preparation of anti-rabbit IgG goat antibody. The control gives a 1: 160 end point titer at final dilution.

• 關聯藥證數量: 1

Ｃ.Ｍ.Ｃ

• 關聯藥證數量: 1

ＣＡＬＩＣＵ

• 關聯藥證數量: 1

ＣＡＲＢＯＸ

• 關聯藥證數量: 1

ＣＡＲＲＯＴ

• 關聯藥證數量: 1

ＣＥＴＹＬ

• 關聯藥證數量: 1

ＣＨＡＭＰＡ

• 關聯藥證數量: 1

ＣＯＩＸ　Ｐ

• 關聯藥證數量: 1

ＣＲＡＭＥＬ

• 關聯藥證數量: 1

ＣＲＹＳＴＡ

• 關聯藥證數量: 1

ＨＹＤＲ　Ｏ

• 關聯藥證數量: 1

ＬＡＣＴＯＳ

• 關聯藥證數量: 1

ＬＡＣＴＯＳＥ

• 關聯藥證數量: 1

ＭＡＧＮＳＩ

• 關聯藥證數量: 1

ＭＥＬ

• 關聯藥證數量: 1

ＭＥＴＹＹＬparaben

• 關聯藥證數量: 1

ＮＥＵＳＩＬ

• 關聯藥證數量: 1

ＮＥＷ　ＣＯ

• 關聯藥證數量: 1

Ｐ　Ｅ　Ｇ

• 關聯藥證數量: 1

ＰＩＮＡＰＰ

• 關聯藥證數量: 1

ＰＯＬＹＯＸ

• 關聯藥證數量: 1

ＰＲＯＰＹＬparaben

• 關聯藥證數量: 1

ＰＶＰ-k３0

• 關聯藥證數量: 1

ＰＶＰ-Ｋ３0

• 關聯藥證數量: 1

ＳＯＡＰ　Ｂ

• 關聯藥證數量: 1

ＳＵＣＲＯＳＥ

• 關聯藥證數量: 1

ＴＡＬＣ

• 關聯藥證數量: 1

ＴＡＲＴＲＡ

• 關聯藥證數量: 1

ＴＥＲＭＩＮ

• 關聯藥證數量: 1

ＴＯＴＡＬ：

• 關聯藥證數量: 1

ＶＡＮＩＬＬ

• 關聯藥證數量: 1

ＷＩＳＴＡＲ

• 關聯藥證數量: 1

ＹＯＧＵＲＴ

• 關聯藥證數量: 1

ｕ　藥

• 關聯藥證數量: 1